Recent Trends in Hemodynamic Monitoring
Growth in the hemodynamic monitoring market is being fueled by several factors, including the aging population and the increasing demand for less invasive and noninvasive technologies for measuring global parameters of oxygen delivery. While barriers to entry are high in the hemodynamic monitoring business, the prospect for future growth is significant.
You may also be interested in...
In March 2013, EarlySense Ltd. gained a US patent for the respiratory trending analysis portion of its EarlySense System, a touch-free monitoring system that detects a patient’s heart rate, respiration, and movement using a sensor placed under the bed mattress. The company is initially targeting the estimated two million medical surgical beds in US and European hospitals in hopes of improving patient safety and reducing preventable adverse events.
Brief summaries of recent medtech market and industry developments. This month we cover China’s switch to a centralized billing system, St. Jude Medical’s RESPECT PFO closure trial, FDA’s approval of HeartWare’s LVAD, and end-of-the-year medtech M&A.
Edwards Lifesciences announced that it was acquiring private Dutch company BMEYE BV, the developer of a new noninvasive technology for hemodynamic monitoring. Noninvasive hemodynamic monitoring has long been “The Holy Grail” in critical care, and non-invasive technology opens up new applications and new markets for Edwards as well.